Risks and Alternatives for Insomnia Treatment with Benzodiazepines

Major Risks of Benzodiazepines

Long-term dependence on benzodiazepines is common, with approximately half of patients prescribed benzodiazepines being treated continuously for at least 12 months despite recommendations against extended use 2
The American Geriatric Society recommends avoiding benzodiazepines in older patients due to increased risk of cognitive impairment, falls, and motor vehicle accidents 3
Benzodiazepines can cause respiratory depression, making them particularly dangerous for patients with respiratory conditions including sleep apnea 1
They are associated with significant next-day impairment, including decreased alertness and driving ability 2

Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia, with better long-term outcomes and minimal side effects 4
Low-dose doxepin (3-6mg) is recommended for sleep maintenance insomnia with fewer risks than benzodiazepines 1
Non-benzodiazepine benzodiazepine receptor agonists (Z-drugs) may be considered for short-term use with generally less disruption of normal sleep architecture than benzodiazepines, and should be used at the lowest effective dose and for the shortest possible duration due to their own risk profile 2

If benzodiazepines must be used, they should be prescribed at the lowest effective dose and for the shortest period possible (less than 4 weeks) 5
Careful monitoring for adverse effects is essential, particularly in elderly patients 4
Administration on an empty stomach is advised to maximize effectiveness and potentially allow for lower dosing 6